Jonas Santol

Years Active: 2023-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yawen Dong, Jonas Santol, Birgit Gruenberger, Alfred Lenauer, Friedrich Laengle, Josef Thaler, Gudrun Piringer, Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers 16 (5) (2024)
Yawen Dong, Jonas Santol, Birgit Gruenberger, Alfred Lenauer, Friedrich Laengle, Josef Thaler, Gudrun Piringer, Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers 16 (5) (2024)
Rebecca Thonhauser, Marcus Poglitsch, Jan Philipp Jonas, Yawen Dong, Madita Tschögl, Mariel Gramberger, Mohamed Salem, Jonas Santol, Irmgard Brandl, Martin Klimpfinger, Constantin Vierziger, Thomas Gruenberger
The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer. Cancers 15 (11) (2023)

Jonas Santol.css-eqlu8i{font-size:small;padding-left:4px;}